Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Biodesix (BDSX) Long-Term Debt Issuances: 2019-2022

Historic Long-Term Debt Issuances for Biodesix (BDSX) over the last 1 years, with Dec 2022 value amounting to $30.0 million.

  • Biodesix's Long-Term Debt Issuances was N/A to $30.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $45.2 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2023, which is 77.83% down from last year.
  • Latest data reveals that Biodesix reported Long-Term Debt Issuances of $30.0 million as of Q4 2022, which was up 100.01% from $15.0 million recorded in Q2 2022.
  • In the past 5 years, Biodesix's Long-Term Debt Issuances registered a high of $30.0 million during Q1 2021, and its lowest value of $78,000 during Q2 2021.
  • Over the past 3 years, Biodesix's median Long-Term Debt Issuances value was $6.5 million (recorded in 2020), while the average stood at $12.6 million.
  • Data for Biodesix's Long-Term Debt Issuances shows a peak YoY increase of 19,129.49% (in 2022) and a maximum YoY decrease of 99.66% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Biodesix's Long-Term Debt Issuances stood at $3.0 million in 2019, then reached $6.5 million in 2020, then tumbled by 98.81% to $78,000 in 2021, then surged by 19,129.49% to $30.0 million in 2022.
  • Its Long-Term Debt Issuances was $30.0 million in Q4 2022, compared to $15.0 million in Q2 2022 and $103,000 in Q1 2022.